For the year ending 2025-12-31, CVSI made $13,789K in revenue. -$958K in net income. Net profit margin of -6.95%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Product sales, net | 13,789 | 15,705 | ||
| Cost of goods sold | 7,037 | 8,537 | ||
| Gross profit | 6,752 | 7,168 | ||
| Research and development | 122 | 118 | ||
| Selling, general and administrative | 7,622 | 9,240 | ||
| Benefit from reversal of accrued payroll taxes (note 12) | -522 | - | ||
| Total operating expenses | 7,222 | 9,358 | ||
| Operating loss | -470 | -2,190 | ||
| Gain on extinguishment of debt | 38 | - | ||
| Other expense, net | - | -212 | ||
| Interest expense, net | 517 | - | ||
| Loss before income taxes | -949 | -2,402 | ||
| Income tax expense (benefit) | 9 | -8 | ||
| Net loss | -958 | -2,394 | ||
| Basic EPS | -0.01 | -0.01 | ||
| Diluted EPS | -0.01 | -0.01 | ||
| Basic Average Shares | 184,264,000 | 175,585,000 | ||
| Diluted Average Shares | 184,264,000 | 175,585,000 | ||
CV Sciences, Inc. (CVSI)
CV Sciences, Inc. (CVSI)